Today's Pre-Market Stock Movers: NIO, PATH, COUP, RKLB and More
Gapping up
In reaction to earnings/guidance:
• $Coupa Software(COUP.US$ +12% (also authorizes new $100mln share repurchase program), $REV Group(REVG.US$ -5%, $G-III Apparel Group(GIII.US$ + 2.1%, $Gitlab(GTLB.US$ +1.2%
Other news:
• $Viewray(VRAY.US$ +3.1% (receives China NMPA approval of its MRIdian MRI-Guided Radiation Therapy)
Gapping down
In reaction to earnings/guidance:
• $UiPath(PATH.US$ -21.6%, $NIO Inc(NIO.US$ -5.8%, $Newell Brands(NWL.US$ -4.6%, $Avid Bioservices(CDMO.US$ -2.3%, $Guidewire Software(GWRE.US$ -1%
Other news:
• $Bicycle Therapeutics(BCYC.US$ -4% (PhaseIdose escalation top-line results from its Phase I/II trial of BT5528)
• $Nektar Therapeutics(NKTR.US$ -2.7% (Presents Data for Rezpegaldesleukin (LY3471851) in Patients with Atopic Dermatitis and Psoriasis from Two Separate Clinical Studies at 2022 European Academy of Dermatology (EADV) Congress)
• $Evelo Biosciences(EVLO.US$ -2.6% (Presents Biomarker Data Demonstrating Anti-inflammatory Effects of EDP1815)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
71750344 : Is NIO still a buy? There has been so much dissing of NIO, I can’t figure out why. I own several shares of NIO and watched my successful choice and investment really dwindle in value.
bullshyt 71750344: hold on and u will see light at the end of the tunnel.
WallStreetYoda : Something big might come out of this crazy profit potential